Billy Evans, partner of the founder of Theranos, Elizabeth Holmes, works on a new startup that seeks to offer “optimization of human health” thanks to blood tests, according to the New York Times.
The Times would have spoken to two investors presented on the startup, called Hanthus, and also saw some of the Hanthus marketing equipment.
In these materials, the company claims to have developed a machine that uses lasers to analyze blood, saliva and urine samples to detect cancer and infections. He plans to start with the health of pets before expanding humans, and he seeks to collect more than $ 50 million.
The height echoes that of Theranos, which has promised to carry out a variety of medical tests on tiny amounts of blood taken from the spicy fingers. In 2022, Holmes (with whom Evans has two children) was sentenced to 11 years in prison for having fraudd investors, although she declared in a recent interview that she remains “completely engaged in my dream of providing each of the affordable health care solutions”.
Facebook investor Jim Breyer told Times that his team had been invited to invest but refused “for several of the same reasons that we have achieved twice on Theranos”.
